Current and Emerging Applications of cell-free DNA Tumor Tests
CME and CMLE credits are not available for this webinar.
This webinar is a recorded presentation of a live broadcast and includes a pre-test, the presentation, handout, and a post-test.
Description:
Circulating cell-free DNA (cfDNA)-based testing is rapidly becoming an integral part of oncology care. Technical advances are allowing detection of a range of genomic alterations for diagnosis, prognosis, treatment selection and disease monitoring to support unique patient care needs at different stages of the care cycle. An evidence-based framework is important in evaluating tumor type and biomarker specific evidence for clinical applications. This presentation will include discussion on existing and emerging clinical and technical applications of cfDNA tumor tests.
Learning Objectives:
1. Evaluate existing evidence for clinical liquid biopsy applications in oncology.
2. Discuss emerging applications of ctDNA testing in oncology practices.
3. Develop strategies to evaluate different genomic alterations using cfDNA.
 |
 |
|---|---|
| Speaker: Keyur Patel, MD, PhD |
Moderator: Marjorie Parker David, MD, MS |
Duration: 1 hr
Level of Instruction: Basic
CME and CMLE credits are not available for this certificate program.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation
